查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1905133

日本抗生素市场报告（按作用机制、药物类别、抗菌谱、给药途径、最终用户和地区划分，2026-2034年）

Japan Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本抗生素市场规模达33.758亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到60.744亿美元，2026年至2034年期间的复合年增长率（CAGR）为6.75%。传染病日益流行，导致手术、医疗程序和住院治疗增多，从而增加了对抗生素的需求，这是推动市场成长的主要因素。

本报告解答的关键问题：

  • 日本抗生素市场目前的表现如何？未来几年又将如何发展？
  • 新冠疫情对日本抗生素市场产生了哪些影响？
  • 日本抗生素市场依作用机制分類的组成是怎样的？
  • 日本抗生素市场依药物类别分類的组成是怎样的？
  • 日本抗生素市场依抗菌谱分類的组成是怎样的？
  • 日本抗生素市场依给药途径分類的组成是怎样的？
  • 日本抗生素市场以最终用户分類的组成是怎样的？
  • 日本抗生素市场价值链的各个阶段有哪些？
  • 日本抗生素产业的主要驱动因素和挑战是什么？
  • 日本抗生素市场的结构是怎么样的？主要参与者有哪些？
  • 日本抗生素市场的竞争程度如何？

目录

第一章：序言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 数据来源
  • 市场估算
  • 预测方法

第三章：执行概要

第四章：日本抗生素市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本抗生素市场概况

  • 历史及当前市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本抗生素市场－依作用机制划分

  • 细胞壁合成抑制剂
  • 蛋白质合成抑制剂
  • DNA合成抑制剂
  • RNA合成抑制剂
  • 分枝菌酸抑制剂
  • 其他的

第七章：日本抗生素市场－依药物类别划分

  • 头孢菌素
  • 青霉素
  • 氟喹诺酮
  • 大环内酯类
  • 碳青霉烯类
  • 氨基糖苷类
  • 其他的

第八章：日本抗生素市场－依抗菌谱划分

  • 广效抗生素
  • 窄谱抗生素

第九章：日本抗生素市场－依给药途径划分

  • 口服
  • 肠外
  • 主题
  • 其他的

第十章：日本抗生素市场－以最终用户划分

  • 医院
  • 专科诊所
  • 其他的

第十一章：日本抗生素市场－按地区划分

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十二章：日本抗生素市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争格局分析
  • 公司评估象限

第十三章：关键参与者简介

第十四章：日本抗生素市场－产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十五章：附录

简介目录
Product Code: SR112026A18083

Japan antibiotics market size reached USD 3,375.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 6,074.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.75% during 2026-2034. The escalating prevalence of infectious diseases, which also leads to surgeries, medical procedures, and hospitalizations, thereby increasing the need for antibiotics to prevent and treat such conditions, is primarily driving the market.

Antibiotics are powerful medications used to treat bacterial infections. They work by targeting and killing bacteria or inhibiting their growth. Antibiotics can be categorized into several classes, each with its unique mechanism of action. They are prescribed by healthcare professionals after diagnosing a bacterial infection. It's crucial to use antibiotics as directed and complete the prescribed course to ensure the complete eradication of bacteria. Failure to do so can lead to antibiotic resistance, where bacteria become less responsive to these drugs. While antibiotics are effective against bacteria, they do not work on viral infections like the common cold or flu. Overuse or misuse of antibiotics has raised concerns about the development of antibiotic-resistant strains of bacteria, making it essential to use them judiciously and only when necessary. Research into new antibiotics and alternative treatments continues to be a critical area of focus in healthcare to combat evolving bacterial threats.

Japan Antibiotics Market Trends:

The antibiotics market in Japan has witnessed significant growth over the years, and several key drivers have propelled this upward trajectory. Firstly, the rise in bacterial infections has necessitated an increased demand for antibiotics. Additionally, the expansion of the geriatric population, which is more susceptible to infections, has further fueled this need. Moreover, advancements in biotechnological methods have led to the discovery of novel antibiotics, thus expanding the market. Furthermore, the spread of antibiotic-resistant pathogens has created an urgency to invest in R&D, leading to more innovations and developments in the sector. Notably, the increasing support and funding from both government and private entities have been pivotal in pushing forward research initiatives. Another crucial factor is the growing awareness among people about bacterial infections and their implications, coupled with easy access to healthcare facilities. Consequently, there is a steady growth in antibiotic prescriptions, boosting the market. On the other hand, though the need for effective treatment regimens is undeniable, there are concerns about antibiotic overuse, potentially causing resistance. Nevertheless, the overall need for effective antibacterial treatments remains paramount, and these market drivers play a crucial role in shaping the industry's landscape.

Japan Antibiotics Market Segmentation:

Action Mechanism Insights:

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Others

Drug Class Insights:

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolide
  • Carbapenem
  • Aminoglycoside
  • Others

Spectrum of Activity Insights:

  • Broad-Spectrum Antibiotics
  • Narrow-Spectrum Antibiotics

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan antibiotics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan antibiotics market?
  • What is the breakup of the Japan antibiotics market on the basis of action mechanism?
  • What is the breakup of the Japan antibiotics market on the basis of drug class?
  • What is the breakup of the Japan antibiotics market on the basis of spectrum of activity?
  • What is the breakup of the Japan antibiotics market on the basis of route of administration?
  • What is the breakup of the Japan antibiotics market on the basis of end user?
  • What are the various stages in the value chain of the Japan antibiotics market?
  • What are the key driving factors and challenges in the Japan antibiotics?
  • What is the structure of the Japan antibiotics market and who are the key players?
  • What is the degree of competition in the Japan antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Antibiotics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Antibiotics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Antibiotics Market - Breakup by Action Mechanism

  • 6.1 Cell Wall Synthesis Inhibitors
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Protein Synthesis Inhibitors
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 DNA Synthesis Inhibitors
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 RNA Synthesis Inhibitors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Mycolic Acid Inhibitors
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Others
    • 6.6.1 Historical and Current Market Trends (2020-2025)
    • 6.6.2 Market Forecast (2026-2034)

7 Japan Antibiotics Market - Breakup by Drug Class

  • 7.1 Cephalosporin
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Penicillin
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Fluoroquinolone
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Macrolide
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Carbapenem
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Aminoglycoside
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2020-2025)
    • 7.7.2 Market Forecast (2026-2034)

8 Japan Antibiotics Market - Breakup by Spectrum of Activity

  • 8.1 Broad-Spectrum Antibiotics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Narrow-Spectrum Antibiotics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Antibiotics Market - Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Topical
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2020-2025)
    • 9.4.2 Market Forecast (2026-2034)

10 Japan Antibiotics Market - Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Others
    • 10.3.1 Historical and Current Market Trends (2020-2025)
    • 10.3.2 Market Forecast (2026-2034)

11 Japan Antibiotics Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Action Mechanism
    • 11.1.4 Market Breakup by Drug Class
    • 11.1.5 Market Breakup by Spectrum of Activity
    • 11.1.6 Market Breakup by Route of Administration
    • 11.1.7 Market Breakup by End User
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kansai/Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Action Mechanism
    • 11.2.4 Market Breakup by Drug Class
    • 11.2.5 Market Breakup by Spectrum of Activity
    • 11.2.6 Market Breakup by Route of Administration
    • 11.2.7 Market Breakup by End User
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/ Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Action Mechanism
    • 11.3.4 Market Breakup by Drug Class
    • 11.3.5 Market Breakup by Spectrum of Activity
    • 11.3.6 Market Breakup by Route of Administration
    • 11.3.7 Market Breakup by End User
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Action Mechanism
    • 11.4.4 Market Breakup by Drug Class
    • 11.4.5 Market Breakup by Spectrum of Activity
    • 11.4.6 Market Breakup by Route of Administration
    • 11.4.7 Market Breakup by End User
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Action Mechanism
    • 11.5.4 Market Breakup by Drug Class
    • 11.5.5 Market Breakup by Spectrum of Activity
    • 11.5.6 Market Breakup by Route of Administration
    • 11.5.7 Market Breakup by End User
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Action Mechanism
    • 11.6.4 Market Breakup by Drug Class
    • 11.6.5 Market Breakup by Spectrum of Activity
    • 11.6.6 Market Breakup by Route of Administration
    • 11.6.7 Market Breakup by End User
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Action Mechanism
    • 11.7.4 Market Breakup by Drug Class
    • 11.7.5 Market Breakup by Spectrum of Activity
    • 11.7.6 Market Breakup by Route of Administration
    • 11.7.7 Market Breakup by End User
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Action Mechanism
    • 11.8.4 Market Breakup by Drug Class
    • 11.8.5 Market Breakup by Spectrum of Activity
    • 11.8.6 Market Breakup by Route of Administration
    • 11.8.7 Market Breakup by End User
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan Antibiotics Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Product Portfolio
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Product Portfolio
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Product Portfolio
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Product Portfolio
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Product Portfolio
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Antibiotics Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix